company-header-logo-avalon

 

Avalon GloboCare Corp.

Avalon GloboCare (Nasdaq:ALBT) is a clinical-stage biotech company focused on immuno-oncology and cellular medicines. Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.

Nasdaq: ALBT
IR Website: https://ir.avalon-globocare.com/
Headquarters: Freehold, NJ

The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.


TALK TO MANAGEMENT

The Avalon Globocare management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.

Summary

Video: Bezinga Presents an Interview with Avalon GloboCare

Press Release / Library

Investor Presentation

Stock Chart

Stock Detail

SEC Filings

CAR-T Cells and Their Transformational Promise

CAR-T Market Size

Exosomes - What Are They and How is AVCO Using Them?

Regenerative Therapy Market

Current Candidates

Strategic Partnerships

Board of Directors and Advisory Board

Senior Management Bios

Risks & Disclosures

avalon-logo-white

The Avalon GloboCare Corp. management and investor relations team is available to talk to current and potential investors. They're happy to answer your questions and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.

• Directly hear the Avalon GloboCare Corp. story
• Ask your questions
• Submit the form below and someone will get in touch with you as soon as possible

Note: Company management or its representative can only discuss and disclose information that is already available in the public domain. They will do their best to clarify such information to the extent permitted by securities law and industry regulations.